GSK-204981

Study Sponsor: GSK

Study Title

An open-label, low interventional clinical study investigating error rates (critical and overall) prior to any retraining in correct use of the ELLIPTA dry powder inhaler (DPI) compared to other DPIs including; DISKUS, Turbuhaler, HandiHaler and Breezhaler as a monotherapy or in combination, in adult patients with Chronic Obstructive Pulmonary Disease (COPD)

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol/umeclidinium bromide

Sponsor Identification Number

204981

Trial Registry Identification Number(#'s)

NCT03114969

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=204981

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03114969

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Raw data are included within the analysis-ready data for this study and are not provided separately.

Date Added to this Site

July 2020